Kolon TissueGene's osteoarthritis cell and gene therapy candidate TG-C (formerly Invossa) has failed to meet its co-primary ...

Korea has approved two new advanced regenerative medicine clinical studies aimed at treating patients with advanced liver cancer and diffuse large B-cell lymphoma (DLBCL), the most common type of ...

Seoul National University Bundang Hospital (SNUBH) announced Friday that its Specialized Public Medical Center for Children ...

Samsung Bioepis reported higher revenue and operating profit for the first half of 2026, driven by continued growth in its ...

GC Biopharma said Friday that it will submit later in the day an investigational new drug (IND) application to the Ministry ...

EuBiologics said Friday that it has completed registration of a Type IV Drug Master File (DMF) for its EcML vaccine adjuvant platform with the U.S. FDA and has been assigned a DMF number.The newly reg ...

Hanmi Pharmaceutical said Friday it has developed a proprietary AI platform capable of predicting the pharmacological ...

Researchers at Seoul National University Hospital (SNUH) have uncovered how the EZH1 Q571R mutation, a genetic alteration ...

Celltrion said Friday it has submitted a marketing authorization application to the European Medicines Agency (EMA) for CT-P55, its biosimilar of the autoimmune disease treatment Cosentyx (secukinumab ...

Oscotec Inc. has completed the inheritance process following the death of its founder and former Chairman Kim Jung-geun, with ...

Efforts by the medical community to designate severe IgA nephropathy as a rare disease to improve patient access to treatment ...

HLB, a Korean cancer drug developer, said Friday that it has completed a late-cycle meeting with the U.S. FDA as part of the ...